147 related articles for article (PubMed ID: 8608525)
1. Urinary 6 beta-hydroxycortisol excretion in Hong Kong Chinese patients with hepatocellular carcinoma and other chronic liver diseases.
Ng MC; Young RP; Critchley JA; Leung NW; Lau JW; Li AK
Cancer; 1996 Apr; 77(8):1427-33. PubMed ID: 8608525
[TBL] [Abstract][Full Text] [Related]
2. A simple non-invasive procedure for the investigation of cytochrome P-450 IIIA dependent enzymes in humans.
Bienvenu T; Rey E; Pons G; d'Athis P; Olive G
Int J Clin Pharmacol Ther Toxicol; 1991 Nov; 29(11):441-5. PubMed ID: 1800391
[TBL] [Abstract][Full Text] [Related]
3. Significance of thymidine phosphorylase in HCC with chronic liver disease for long-term postoperative recurrence.
Ezaki T; Ikegami T; Ishida T; Aimitsu S; Mori M; Fujihara M
J Surg Oncol; 2003 Jul; 83(3):173-9; discussion 179. PubMed ID: 12827687
[TBL] [Abstract][Full Text] [Related]
4. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
6. Implications of serum basic fibroblast growth factor levels in chronic liver diseases and hepatocellular carcinoma.
Hsu PI; Chow NH; Lai KH; Yang HB; Chan SH; Lin XZ; Cheng JS; Huang JS; Ger LP; Huang SM; Yen MY; Yang YF
Anticancer Res; 1997; 17(4A):2803-9. PubMed ID: 9252719
[TBL] [Abstract][Full Text] [Related]
7. [6 beta-hydroxycortisol: a non-invasive reflection of enzymes of drug metabolism].
Zhiri A; Wellman-Bednawska M; Siest G
Pathol Biol (Paris); 1987 Sep; 35(7):1087-93. PubMed ID: 3313218
[TBL] [Abstract][Full Text] [Related]
8. Rapid kinetic rate assay of the serum alpha-L-fucosidase in patients with hepatocellular carcinoma by using a novel substrate.
Wang JJ; Cao EH
Clin Chim Acta; 2004 Sep; 347(1-2):103-9. PubMed ID: 15313147
[TBL] [Abstract][Full Text] [Related]
9. The variability of liver graft function and urinary 6beta-hydroxycortisol to cortisol ratio during liver regeneration in liver transplant recipients.
Kishino S; Ogawa M; Takekuma Y; Sugawara M; Shimamura T; Furukawa H; Todo S; Miyazaki K
Clin Transplant; 2004 Apr; 18(2):124-9. PubMed ID: 15016124
[TBL] [Abstract][Full Text] [Related]
10. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
Ushiama H; Echizen H; Nachi S; Ohnishi A
Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
[TBL] [Abstract][Full Text] [Related]
12. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
Elsammak MY; Amin GM; Khalil GM; Ragab WS; Abaza MM
Clin Biochem; 2006 Jun; 39(6):623-9. PubMed ID: 16624274
[TBL] [Abstract][Full Text] [Related]
13. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
Soga K; Watanabe T; Aikawa K; Toshima M; Shibasaki K; Aoyagi Y
Hepatogastroenterology; 1998; 45(23):1737-41. PubMed ID: 9840138
[TBL] [Abstract][Full Text] [Related]
14. Circulating platelet-derived endothelial cell growth factor increases in hepatocellular carcinoma patients.
Jin-no K; Tanimizu M; Hyodo I; Nishikawa Y; Hosokawa Y; Endo H; Doi T; Mandai K; Ishitsuka H
Cancer; 1998 Apr; 82(7):1260-7. PubMed ID: 9529017
[TBL] [Abstract][Full Text] [Related]
15. SEN virus infection in patients with chronic liver disease and hepatocellular carcinoma in Thailand.
Tangkijvanich P; Theamboonlers A; Sriponthong M; Thong-Ngam D; Kullavanijaya P; Poovorawan Y
J Gastroenterol; 2003; 38(2):142-8. PubMed ID: 12640527
[TBL] [Abstract][Full Text] [Related]
16. Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population.
Imaizumi T; Higaki Y; Hara M; Sakamoto T; Horita M; Mizuta T; Eguchi Y; Yasutake T; Ozaki I; Yamamoto K; Onohara S; Kawazoe S; Shigematsu H; Koizumi S; Kudo S; Tanaka K
Carcinogenesis; 2009 Oct; 30(10):1729-34. PubMed ID: 19643819
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of serum and urinary neopterin levels in patients with various liver diseases.
Daito K; Suou T; Kawasaki H
Am J Gastroenterol; 1992 Apr; 87(4):471-6. PubMed ID: 1313206
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive study of urinary cortisol metabolites in hyperthyroid and hypothyroid patients.
Hoshiro M; Ohno Y; Masaki H; Iwase H; Aoki N
Clin Endocrinol (Oxf); 2006 Jan; 64(1):37-45. PubMed ID: 16402926
[TBL] [Abstract][Full Text] [Related]
19. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection.
Yokoi Y; Suzuki S; Baba S; Inaba K; Konno H; Nakamura S
J Gastroenterol; 2005 Mar; 40(3):274-82. PubMed ID: 15830287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
